Bown N, et al. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol 2001 Jan;36(1):14-9
[Related articles] Chromosome 17q
|
Brodeur GM, et al. Biological aspects of neuroblastomas identified by mass screening in Quebec. Med Pediatr Oncol 2001 Jan;36(1):157-9
[Related articles] Screening
|
Burchill SA, et al. Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):213-9
[Related articles] |
Cheung NK, et al. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Med Pediatr Oncol 2001 Jan;36(1):227-30
[Related articles] Trials & Studies
|
Cotterill SJ, et al. Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey". Med Pediatr Oncol 2001 Jan;36(1):235-8
[Related articles] |
Cotterill SJ, et al. Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease Registry. Med Pediatr Oncol 2001 Jan;36(1):231-4
[Related articles] |
Fulda S, et al. Preclinical and clinical aspects on the use of amifostine as chemoprotectorin neuroblastoma patients. Med Pediatr Oncol 2001 Jan;36(1):199-202
[Related articles] |
George RE, et al. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group. Med Pediatr Oncol 2001 Jan;36(1):169-76
[Related articles] MYCN Amplification
|
Hero B, et al. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):220-3
[Related articles] |
Ladenstein R, et al. Prognostic significance of DNA di-tetraploidy in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):83-92
[Related articles] MYCN Amplification Chromosome 1p
|
Rubie H, et al. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Societe Francaise d'Oncologie Pediatrique. Med Pediatr Oncol 2001 Jan;36(1):247-50
[Related articles] Trials & Studies
|
Tang XX, et al. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas. Med Pediatr Oncol 2001 Jan;36(1):80-2
[Related articles] MYCN Amplification
|
Tweddle DA, et al. OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age. Med Pediatr Oncol 2001 Jan;36(1):239-42
[Related articles] Trials & Studies
|
Yoneda A, et al. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study. Med Pediatr Oncol 2001 Jan;36(1):160-2
[Related articles] Screening
|
Ambros IM, et al. Neuroblastoma cells provoke Schwann cell proliferation in vitro. Med Pediatr Oncol 2001 Jan;36(1):163-8
[Related articles] |
Ambros PF, et al. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Med Pediatr Oncol 2001 Jan;36(1):1-4
[Related articles] MYCN Amplification Chromosome 1p
|
Amendola R, et al. DR-nm23 expression affects neuroblastoma cell differentiation, integrin expression, and adhesion characteristics. Med Pediatr Oncol 2001 Jan;36(1):93-6
[Related articles] |
Annicchiarico-Petruzzelli M, et al. Apoptosis in neuroblastomas induced by interferon-gamma involves the CD95/CD95L pathway. Med Pediatr Oncol 2001 Jan;36(1):115-7
[Related articles] |
Babajko S, et al. IGFBPs are involved in xenograft development in nude mice. Med Pediatr Oncol 2001 Jan;36(1):154-6
[Related articles] |
Barrois M, et al. Genomic and allelic expression status of the p73 gene in human neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):45-7
[Related articles] |
Berry PA, et al. Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells. Med Pediatr Oncol 2001 Jan;36(1):142-6
[Related articles] |
Brinkschmidt C, et al. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Med Pediatr Oncol 2001 Jan;36(1):11-3
[Related articles] Chromosome 17q
|
Cheung IY, et al. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE. Med Pediatr Oncol 2001 Jan;36(1):210-2
[Related articles] |
David K, et al. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM. Med Pediatr Oncol 2001 Jan;36(1):251-7
[Related articles] |
Eggert A, et al. TrkA signal transduction pathways in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):108-10
[Related articles] |
Ejeskar K, et al. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours. Med Pediatr Oncol 2001 Jan;36(1):61-6
[Related articles] Chromosome 1p
|
Evans AE, et al. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB. Med Pediatr Oncol 2001 Jan;36(1):181-4
[Related articles] |
Fukuda M, et al. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):147-8
[Related articles] |
Gross N, et al. Role of CD44H carbohydrate structure in neuroblastoma adhesive properties. Med Pediatr Oncol 2001 Jan;36(1):139-41
[Related articles] |
Gross N, et al. Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):111-4
[Related articles] |
Hedborg F, et al. Evidence of chromaffin oxygen sensing in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):149-53
[Related articles] |
Hiyama E, et al. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Med Pediatr Oncol 2001 Jan;36(1):67-74
[Related articles] Chromosome 1p
|
Hogarty MD, et al. Analysis of genomic imprinting at 1p35-36 in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):52-5
[Related articles] Chromosome 1p
|
Horibe K, et al. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):203-4
[Related articles] |
Ichimiya S, et al. Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas. Med Pediatr Oncol 2001 Jan;36(1):42-4
[Related articles] Chromosome 1p
|
Ichimiya S, et al. Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines. Med Pediatr Oncol 2001 Jan;36(1):132-4
[Related articles] |
Katzenstein HM, et al. Antiangiogenic therapy inhibits human neuroblastoma growth. Med Pediatr Oncol 2001 Jan;36(1):190-3
[Related articles] |
Kramer K, et al. Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):194-6
[Related articles] |
Kuroda H, et al. Signaling pathway of ciliary neurotrophic factor in neuroblastoma cell lines. Med Pediatr Oncol 2001 Jan;36(1):118-21
[Related articles] |
Lastowska M, et al. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):20-3
[Related articles] Chromosome 17q
|
Lovat PE, et al. Differential gene regulation by 9-cis and all-trans retinoic acid in neuroblastoma cells. Med Pediatr Oncol 2001 Jan;36(1):135-8
[Related articles] |
Manzke O, et al. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies. Med Pediatr Oncol 2001 Jan;36(1):185-9
[Related articles] |
Maris JM, et al. Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):32-6
[Related articles] Chromosome 1p
|
Maris JM, et al. Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):24-7
[Related articles] |
Matsuo T, et al. Increased expression of p27Kip1 arrests neuroblastoma cell growth. Med Pediatr Oncol 2001 Jan;36(1):97-9
[Related articles] |
Mehes G, et al. Automatic detection and genetic profiling of disseminated neuroblastoma cells. Med Pediatr Oncol 2001 Jan;36(1):205-9
[Related articles] |
Norris MD, et al. Expression of the putative tumour suppressor gene, p73, in neuroblastoma and other childhood tumours. Med Pediatr Oncol 2001 Jan;36(1):48-51
[Related articles] |
Norris MD, et al. Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin. Med Pediatr Oncol 2001 Jan;36(1):177-80
[Related articles] |
Orlando C, et al. Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. Med Pediatr Oncol 2001 Jan;36(1):224-6
[Related articles] |
Ponthan F, et al. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo. Med Pediatr Oncol 2001 Jan;36(1):127-31
[Related articles] |
Raschella G, et al. Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells. Med Pediatr Oncol 2001 Jan;36(1):104-7
[Related articles] |
Schilling FH, et al. Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomas. Med Pediatr Oncol 2001 Jan;36(1):56-60
[Related articles] Chromosome 1p
|
Takada N, et al. Retinoic acid-induced apoptosis of the CHP134 neuroblastoma cell line is associated with nuclear accumulation of p53 and is rescued by the GDNF/Ret signal. Med Pediatr Oncol 2001 Jan;36(1):122-6
[Related articles] |
Thompson PM, et al. Loss of heterozygosity for chromosome 14q in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):28-31
[Related articles] |
Valent A, et al. Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line. Med Pediatr Oncol 2001 Jan;36(1):100-3
[Related articles] |
Van Heek-Romanowski R, et al. Etoposide toxicity on human neuroblastoma cells in vitro is enhanced by preceeding hyperthermia. Med Pediatr Oncol 2001 Jan;36(1):197-8
[Related articles] |
Vandesompele J, et al. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol 2001 Jan;36(1):5-10
[Related articles] MYCN Amplification Chromosome 1p Chromosome 17q
|
White PS, et al. Detailed molecular analysis of 1p36 in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):37-41
[Related articles] Chromosome 1p
|
Whittington HA, et al. Generation of a humanised single chain Fv (Scfv) derived from the monoclonal Eric-1 recognising the human neural cell adhesion molecule. Med Pediatr Oncol 2001 Jan;36(1):243-6
[Related articles] |
Wimmer K, et al. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):75-9
[Related articles] MYCN Amplification
|